Djordjevic Filip, Stewart Ashleigh Cara, Vella-Horne Dylan, Gleeson Zoe, Pavlyshyn Damian, Gill Matthew, Petrovic Rebekka, Scott Nick, Higgs Peter, Roth Alexis, Cocchiaro Ben, Dietze Paul, O'Keefe Daniel
Disease Elimination, Burnet Institute, Melbourne, Victoria, Australia.
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
BMJ Open. 2024 Dec 20;14(12):e091613. doi: 10.1136/bmjopen-2024-091613.
Opioid overdose and blood-borne virus transmission are key health risks for people who inject drugs. Existing study methods that record data on injecting drug risks mostly rely on retrospective self-reporting that, while valid, are limited to being broad and subject to recall bias. The In-The-Moment-Expanded (ITM-Ex) study will evaluate the feasibility and acceptability of multiple novel data collection methods to capture in situ drug injecting data.
ITM-Ex will purposively recruit 50 participants from an existing longitudinal cohort (SuperMIX study) of people who inject drugs in Melbourne, Australia. Over a 4-week study period, participants will be asked to complete baseline/endline spirometry, continuously wear a heart rate monitoring device, complete short-form ecological momentary assessment (EMA) questionnaires for every injecting episode during the study period and return previously used needles/syringes for drug residue testing. These multiple data sources will be combined to conduct a comprehensive analysis of the physiological and risk characteristics of an estimated 800 individual injecting drug use episodes (if participants inject four times weekly). Finally, post-participation qualitative interviews will explore the acceptability of the data collection methods.
Ethics approval for ITM-Ex was obtained from Alfred Hospital Ethics Committee (project number 368/22). Results will be disseminated via national and international scientific and public health conferences and peer-reviewed journal publications.Results from ITM-Ex may demonstrate vastly more complete and accurate methods of capturing data on injecting drug use risk and support future development and evaluation of devices to monitor and intervene during drug overdose. Further, ITM-Ex may demonstrate innovative methodologies to support myriad future public health research studies.
阿片类药物过量使用和血源性病原体传播是注射毒品者面临的主要健康风险。现有的记录注射毒品风险数据的研究方法大多依赖回顾性自我报告,虽然有效,但范围有限且存在回忆偏差。即时扩展(ITM-Ex)研究将评估多种新型数据收集方法用于获取现场毒品注射数据的可行性和可接受性。
ITM-Ex将从澳大利亚墨尔本现有的注射毒品者纵向队列(超级混合研究)中有意招募50名参与者。在为期4周的研究期间,参与者将被要求完成基线/终末肺活量测定,持续佩戴心率监测设备,在研究期间每次注射时完成简短的生态瞬时评估(EMA)问卷,并归还之前使用过的针头/注射器进行药物残留检测。这些多个数据源将被整合起来,对估计800次个体注射毒品使用事件(如果参与者每周注射四次)的生理和风险特征进行全面分析。最后,参与后的定性访谈将探讨数据收集方法的可接受性。
ITM-Ex已获得阿尔弗雷德医院伦理委员会的伦理批准(项目编号368/22)。研究结果将通过国内和国际科学及公共卫生会议以及同行评审的期刊出版物进行传播。ITM-Ex的结果可能会展示出更完整、准确的获取注射毒品使用风险数据的方法,并支持未来监测和干预药物过量的设备的开发和评估。此外,ITM-Ex可能会展示创新方法,以支持未来众多的公共卫生研究。